These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9159016)
81. Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period. Kauppinen K; Stubb S Acta Derm Venereol; 1984; 64(4):320-4. PubMed ID: 6209890 [TBL] [Abstract][Full Text] [Related]
82. Flexural eruption in two hospitalized patients. Lee HY; Philippidou M; Schey S; Selway R; Walsh S; Creamer D Clin Exp Dermatol; 2013 Dec; 38(8):943-5. PubMed ID: 23692428 [No Abstract] [Full Text] [Related]
83. Pustular eruption after drug exposure: is it pustular psoriasis or a pustular drug eruption? Spencer JM; Silvers DN; Grossman ME Br J Dermatol; 1994 Apr; 130(4):514-9. PubMed ID: 8186121 [TBL] [Abstract][Full Text] [Related]
84. Fixed-drug eruption due to metronidazole with positive topical provocation. Gastaminza G; Anda M; Audicana MT; Fernandez E; Muñoz D Contact Dermatitis; 2001 Jan; 44(1):36. PubMed ID: 11156011 [No Abstract] [Full Text] [Related]
85. Multiple fixed drug eruption due to drug combination. Yokoyama A; Hara H Contact Dermatitis; 2005 Jun; 52(6):339-41. PubMed ID: 15932587 [TBL] [Abstract][Full Text] [Related]
86. FIXED DRUG ERUPTION CROSS REACTION OF MEPROBAMATE AND CARISOPRODOL. GORE HC Arch Dermatol; 1965 Jun; 91():627. PubMed ID: 14298818 [No Abstract] [Full Text] [Related]
87. Maculopapular type drug eruption caused by garenoxacin mesilate hydrate: A case report and literature review. Oda T; Sawada Y; Okada E; Nakamura M Australas J Dermatol; 2017 Nov; 58(4):e276-e277. PubMed ID: 28660683 [No Abstract] [Full Text] [Related]
88. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Anderson HJ; Lee JB Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848 [TBL] [Abstract][Full Text] [Related]
89. Fixed drug eruption due to multi-vitamin multi-mineral preparation as part of familial polysensitivity. Gulati R; Bhargava P; Mathur NK J Assoc Physicians India; 1999 Feb; 47(2):253. PubMed ID: 10999109 [No Abstract] [Full Text] [Related]
91. Fixed drug eruption due to tipepidine hibenzate and garenoxacin mesylate hydrate: an unusual case of polysensitivity. Harada Y; Fukuda H Eur J Dermatol; 2024 Feb; 34(1):104-105. PubMed ID: 38557473 [No Abstract] [Full Text] [Related]
92. Fixed drug eruption due to norfloxacin with cross-reactivity to ciprofloxacin: A case report. Alpalhão M; Antunes J; Soares-Almeida L; Correia TE; Filipe P Contact Dermatitis; 2020 Aug; 83(2):135-137. PubMed ID: 32243605 [No Abstract] [Full Text] [Related]
93. Polysensitivity and familiar occurrence in fixed drug eruption. Bhargava P; Kuldeep CM; Mathur NK Int J Dermatol; 1997 Mar; 36(3):236. PubMed ID: 9159016 [No Abstract] [Full Text] [Related]
94. Generalized fixed drug eruption to piperacillin/tazobactam and review of literature. Kornmehl H; Gorouhi F; Konia T; Fung MA; Tartar DM Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906010 [TBL] [Abstract][Full Text] [Related]